GB1388786A - Integral solid gel-lattice dosage form of high-moisture content - Google Patents
Integral solid gel-lattice dosage form of high-moisture contentInfo
- Publication number
- GB1388786A GB1388786A GB1130873A GB1130873A GB1388786A GB 1388786 A GB1388786 A GB 1388786A GB 1130873 A GB1130873 A GB 1130873A GB 1130873 A GB1130873 A GB 1130873A GB 1388786 A GB1388786 A GB 1388786A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lattice
- gel
- cellulose
- histamine
- active compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 235000010443 alginic acid Nutrition 0.000 abstract 2
- 229920000615 alginic acid Polymers 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000499 gel Substances 0.000 abstract 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 abstract 2
- CAVQBDOACNULDN-KHFUBBAMSA-N (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-KHFUBBAMSA-N 0.000 abstract 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 abstract 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 abstract 1
- 229920001817 Agar Polymers 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 241000416162 Astragalus gummifer Species 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 102000011632 Caseins Human genes 0.000 abstract 1
- 108010076119 Caseins Proteins 0.000 abstract 1
- 241001310324 Cetraria islandica Species 0.000 abstract 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 abstract 1
- 241000206575 Chondrus crispus Species 0.000 abstract 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 244000303965 Cyamopsis psoralioides Species 0.000 abstract 1
- IROWCYIEJAOFOW-UHFFFAOYSA-N DL-Isoprenaline hydrochloride Chemical compound Cl.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 IROWCYIEJAOFOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 240000007472 Leucaena leucocephala Species 0.000 abstract 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 abstract 1
- 239000004368 Modified starch Substances 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 229920001615 Tragacanth Polymers 0.000 abstract 1
- 239000008272 agar Substances 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000002579 antinauseant Substances 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002327 chloral hydrate Drugs 0.000 abstract 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 229920001577 copolymer Chemical compound 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- MZDOIJOUFRQXHC-UHFFFAOYSA-N dimenhydrinate Chemical compound O=C1N(C)C(=O)N(C)C2=NC(Cl)=N[C]21.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 MZDOIJOUFRQXHC-UHFFFAOYSA-N 0.000 abstract 1
- 229960004993 dimenhydrinate Drugs 0.000 abstract 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 229940018448 isoproterenol hydrochloride Drugs 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 230000002475 laxative effect Effects 0.000 abstract 1
- MKXZASYAUGDDCJ-CGTJXYLNSA-N levomethorphan Chemical compound C([C@H]12)CCC[C@@]11CCN(C)[C@@H]2CC2=CC=C(OC)C=C21 MKXZASYAUGDDCJ-CGTJXYLNSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000011976 maleic acid Substances 0.000 abstract 1
- 239000000155 melt Substances 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000019426 modified starch Nutrition 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 235000015424 sodium Nutrition 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 239000000196 tragacanth Substances 0.000 abstract 1
- 235000010487 tragacanth Nutrition 0.000 abstract 1
- 229940116362 tragacanth Drugs 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/025—Applications of microcapsules not provided for in other subclasses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24083472A | 1972-04-03 | 1972-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1388786A true GB1388786A (en) | 1975-03-26 |
Family
ID=22908131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1130873A Expired GB1388786A (en) | 1972-04-03 | 1973-03-08 | Integral solid gel-lattice dosage form of high-moisture content |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5116926B2 (enrdf_load_stackoverflow) |
| CA (1) | CA1041905A (enrdf_load_stackoverflow) |
| DE (1) | DE2316242A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2179044B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1388786A (enrdf_load_stackoverflow) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU577213B2 (en) * | 1985-12-19 | 1988-09-15 | Capsoid Pharma Gmbh | Process for producing shapes for administering individual doses |
| US4801460A (en) * | 1986-04-11 | 1989-01-31 | Basf Aktiengesellschaft | Preparation of solid pharmaceutical forms |
| US5525351A (en) * | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
| RU2108099C1 (ru) * | 1989-11-07 | 1998-04-10 | Дам Андерс | Растворимый в слюне препарат для исключения курения табака |
| WO1999017744A1 (en) * | 1997-10-07 | 1999-04-15 | Fuisz Technologies Ltd. | Immediate release drug delivery forms |
| US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
| US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
| US6221368B1 (en) | 1996-09-13 | 2001-04-24 | Basf Aktiengesellschaft | Process for producing solid dosage forms by extrusion |
| WO2006125857A1 (en) * | 2005-05-26 | 2006-11-30 | Mika Tapio Reijonen | Composition and manufacturing process of cetraria islandica based polymer blend |
| WO2009124763A3 (en) * | 2008-04-10 | 2010-04-01 | Biophil S.R.L. | Dermal patch comprising chondrus crispus extract |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU43437B (en) * | 1976-05-05 | 1989-08-31 | Lowey Hans | Process for obtaining tablets containing an active component with long lasting effect |
| IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
| FR2372600A1 (fr) * | 1976-12-01 | 1978-06-30 | Merck & Co Inc | Composition epaississante pour assaisonnement pour la salade, maniable a la cuiller et exempt d'amidon |
| FR2515035A1 (fr) * | 1981-10-26 | 1983-04-29 | Rhone Poulenc Sante | Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication |
| US5229164A (en) * | 1985-12-19 | 1993-07-20 | Capsoid Pharma Gmbh | Process for producing individually dosed administration forms |
| DE4226753A1 (de) * | 1992-08-13 | 1994-02-17 | Basf Ag | Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| DE4446380A1 (de) * | 1994-07-05 | 1996-01-11 | Lohmann Therapie Syst Lts | Hydrogel für die Applikation von therapeutischen und/oder kosmetischen Wirkstoffen an die Haut |
| FR2725624B1 (fr) * | 1994-10-14 | 1997-01-17 | Jouveinal Inst Rech | Procede de preparation de formes pharmaceutiques a liberation controlee |
| GB9626152D0 (en) * | 1996-12-17 | 1997-02-05 | Cehmcolloids Ltd | Encapsulation |
| EP1028713A1 (en) * | 1997-11-12 | 2000-08-23 | The Dow Chemical Company | A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition |
| AU8621398A (en) * | 1998-01-12 | 1999-07-26 | Buhler Ag | Method and device for capsulating active ingredients |
-
1973
- 1973-03-08 GB GB1130873A patent/GB1388786A/en not_active Expired
- 1973-03-26 CA CA167,309A patent/CA1041905A/en not_active Expired
- 1973-03-31 DE DE2316242A patent/DE2316242A1/de active Pending
- 1973-04-03 JP JP48038190A patent/JPS5116926B2/ja not_active Expired
- 1973-04-03 FR FR7311945A patent/FR2179044B1/fr not_active Expired
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU577213B2 (en) * | 1985-12-19 | 1988-09-15 | Capsoid Pharma Gmbh | Process for producing shapes for administering individual doses |
| US4801460A (en) * | 1986-04-11 | 1989-01-31 | Basf Aktiengesellschaft | Preparation of solid pharmaceutical forms |
| AU587897B2 (en) * | 1986-04-11 | 1989-08-31 | Basf Aktiengesellschaft | Preparation of solid pharmaceutical forms |
| US6110495A (en) * | 1989-11-07 | 2000-08-29 | Dam; Anders | Nicotine containing stimulant unit |
| US5733574A (en) * | 1989-11-07 | 1998-03-31 | Dam; Anders | Nicotine containing stimulant unit |
| RU2108099C1 (ru) * | 1989-11-07 | 1998-04-10 | Дам Андерс | Растворимый в слюне препарат для исключения курения табака |
| US5525351A (en) * | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
| US6221368B1 (en) | 1996-09-13 | 2001-04-24 | Basf Aktiengesellschaft | Process for producing solid dosage forms by extrusion |
| US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
| WO1999017744A1 (en) * | 1997-10-07 | 1999-04-15 | Fuisz Technologies Ltd. | Immediate release drug delivery forms |
| US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
| WO2006125857A1 (en) * | 2005-05-26 | 2006-11-30 | Mika Tapio Reijonen | Composition and manufacturing process of cetraria islandica based polymer blend |
| WO2009124763A3 (en) * | 2008-04-10 | 2010-04-01 | Biophil S.R.L. | Dermal patch comprising chondrus crispus extract |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5116926B2 (enrdf_load_stackoverflow) | 1976-05-28 |
| FR2179044A1 (enrdf_load_stackoverflow) | 1973-11-16 |
| DE2316242A1 (de) | 1973-12-06 |
| FR2179044B1 (enrdf_load_stackoverflow) | 1980-05-23 |
| CA1041905A (en) | 1978-11-07 |
| JPS499480A (enrdf_load_stackoverflow) | 1974-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1388786A (en) | Integral solid gel-lattice dosage form of high-moisture content | |
| EP0214735B1 (en) | Controlled release pharmaceutical composition | |
| US4792452A (en) | Controlled release formulation | |
| US4309404A (en) | Sustained release pharmaceutical compositions | |
| EP0822809A4 (en) | SLOW RELEASE FORMULATION OF WATER SOLUBLE DRUGS WITH INCORPORATED PASSAGE | |
| CA2198917A1 (en) | Sustained release of peptides from pharmaceutical compositions | |
| NO20065390L (no) | Farmasoytisk preparat i fast enhetsdoseringsform | |
| IL106693A (en) | Controlled sustained release tablets containing bupropion hydrochloride | |
| YU31599A (sh) | Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze | |
| CA2433186A1 (en) | Delayed release pharmaceutical formulations | |
| ATE229327T1 (de) | Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen | |
| IE891795L (en) | Pharmaceutical compositions for piperidinoalkanol-ibuprofen¹combination | |
| CA2374020A1 (en) | Simple culture medium and method for preparation thereof | |
| GR1003658B (el) | Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου | |
| HU9301672D0 (en) | Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents | |
| Selzer et al. | An experimental study of senecio poisoning in rats | |
| BE903029A (fr) | Nouvelles formes pharmaceutiques administrables par voie nasale. | |
| DE59401833D1 (de) | Retardmikrotablette von beta-phenylpropiophenonderivaten | |
| US4428951A (en) | Long acting pharmaceutical composition | |
| JPS5726615A (en) | Improving method for absorbability of slightly soluble drug | |
| GB1445995A (en) | Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof | |
| US6740340B1 (en) | Pharmaceutical tablets comprising an NSAID and a prostaglandin | |
| IE802033L (en) | Dibenzazepine derivatives | |
| ES8502076A1 (es) | Procedimiento para la preparacion de acido 3b-(3-carboxipropioniloxi)-ursa-9(11),12-dien-28-oico | |
| SE9401480D0 (sv) | A new 78 residue polypeptide (NK-lysine) and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |